Rare diseases
Investigational molecules
Locations
1000 Mylan Boulevard, 15317-5853, United States
Clinical research activity is centered on major depressive disorder, with attention to patients whose symptoms remain insufficiently controlled by existing antidepressant therapy. The sponsor’s studies examine both oral and injectable approaches used alongside ongoing antidepressant treatment.
Outcomes are focused on changes in established depression rating scales and the broader management of persistent depressive symptoms.
Clinical trials run by this sponsor – those enrolling participants first.
ItalyItalyIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
